EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks

Heather Walker iD, Juan-Jesus Carrero iD, Michael K Sullivan iD, Ryan Field, Anne-Laure Faucon iD, Jennifer S Lees iD, Edouard L Fu iD, Bhautesh Dinesh Jani iD, Katie Gallacher iD, Patrick B Mark iD

Nephrology Dialysis Transplantation · 2026

DOI: 10.1093/ndt/gfaf252 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Nephrology Dialysis Transplantation, 2026. Verfasst von Heather Walker und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Multimorbidity, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VENI, Wellcome Trust, Dutch Kidney Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and hypothesis Guidelines recommend using risk prediction models for predicting kidney failure in chronic kidney disease (CKD). Many people with CKD have multiple long-term conditions (multimorbidity), which influences outcomes including kidney failure and mortality. This study validated the four-variable kidney failure risk equation (KFRE) in individuals with CKD, with and without multimorbidity, comparing performance of KFRE using creatinine and cystatin C to calculate estimated glomerular filtration rate (eGFR) and updated the model to account for competing mortality risks.

Methods

Observational cohort study using research-based (UK Biobank) and population-based cohorts (Stockholm Creatinine Measurements project: SCREAM). Multimorbidity was defined as two or more long-term conditions in addition to CKD. Kidney failure was defined as long-term dialysis or kidney transplantation. KFRE performance assessment included discrimination, calibration, and overall fit at 2 and 5 years. An updated model (using the same variables as KFRE) accounting for competing mortality risks was developed and validated.

Results

14 998 of 24 489 individuals in UK Biobank (61.2%) and 30 147 of 42 902 individuals in SCREAM (70.3%) had multimorbidity. Discrimination of KFRE was good (area under curve $\ge $0.86 across eGFR equations in all cohorts, multimorbidity groups and time horizons). Kidney failure risk was under-estimated in people with multimorbidity in UK Biobank (observed/expected (O/E) ratio 1.75 at 5 years; eGFR creatinine). Conversely, calibration-in-the-large (O/E ratio) at 5 years in SCREAM was 1.05 in the multimorbidity group (eGFR creatinine). Using cystatin C compared to creatinine did not improve model performance. Cumulative incidence of death was higher with multimorbidity compared to no multimorbidity. An updated model considering competing mortality improved calibration performance over KFRE, O/E ratio 0.98 in multimorbidity group of the validation cohort (UK Biobank) at 5 years.

Conclusion

Competing mortality risk is important when predicting kidney failure, particularly for people with multimorbidity. An updated model accounting for competing mortality risk, permits improved model performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MultimorbidityRenal Insufficiency, ChronicHumansFemaleGlomerular Filtration RateMaleMiddle AgedPrognosisAgedRisk FactorsCreatinineFollow-Up StudiesRisk AssessmentKidney Function TestsCystatin CSurvival RateCohort Studies

Stichwörter der Autor:innen

CKDKFREchronic renal failurecompeting risk analysisprognostic model

Substanzen

CreatinineCystatin C

Autor:innen und Institutionen

  • School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Renal and Transplant Unit, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.
  • Health Economics and Health Technology Assessment, School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  • General Practice and Primary Care, School of Health and Wellbeing, University of Glasgow, Glasgow, UK.

ORCID-Profile: Heather Walker, Juan-Jesus Carrero, Michael K Sullivan, Anne-Laure Faucon, Jennifer S Lees, Edouard L Fu, Bhautesh Dinesh Jani, Katie Gallacher, Patrick B Mark

Förderung

  • VENI
  • Wellcome Trust
  • Dutch Kidney Foundation

Zitieren

APA

Walker, H., Carrero, J. J., Sullivan, M. K., Field, R., Faucon, A. L., Lees, J. S., Fu, E. L., Jani, B. D., Gallacher, K., & Mark, P. B. (2026). The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf252

Vancouver

Walker H, Carrero JJ, Sullivan MK, Field R, Faucon AL, Lees JS, et al. The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfaf252

BibTeX
@article{Walker2026,
  author = {Walker, Heather and Carrero, Juan-Jesus and Sullivan, Michael K and Field, Ryan and Faucon, Anne-Laure and Lees, Jennifer S and Fu, Edouard L and Jani, Bhautesh Dinesh and Gallacher, Katie and Mark, Patrick B},
  title = {The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  doi = {10.1093/ndt/gfaf252}
}
Kostenlos starten →